https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
A substantial fraction of HNSCC overexpresses HER2 protein, suggesting it may be a suitable target for antigen-directed immunotherapy. HER2 expression and its correlation with survival vary across HNSCC subsites, making it unsuitable as a prognostic marker. To report the clinical characteristics of the largest single centre cohort of patients with eosinophilic sialodochitis. Analysis of data relating to 37 patients seen in a dedicated multidisciplinary clinic was performed. Demographic, clinical, haematological, cytological,
Like
Comment
Share
